- The partnership leverages Docquity’s AI capabilities and exMedio’s doctor network in Japan to enhance healthcare decision-making and patient outcomes
- Collaboration will begin with a Proof of Concept integrating Docquity’s Dx technology into exMedio’s Hippocra platform reaching more than 74,000 physicians from June to September 2025
TOKYO, JAPAN, 16 June 2025 – Docquity, leading healthtech company in Southeast Asia, and exMedio, a trusted provider of digital solutions for doctors in Japan, today announced a partnership harnessing generative artificial intelligence (AI) to empower Japanese doctors with stronger clinical decision-making capabilities for improved patient care. Docquity will integrate Dx, its AI-powered tool for clinical-decision support, into exMedio’s Hippocra, a doctor-only community connecting tens of thousands in Japan.
Built upon Docquity’s network insights as the largest healthcare professional (HCP) community in Southeast Asia, Dx leverages compliant Generative AI to provide HCPs with the latest evidence-based healthcare knowledge for enhanced treatment decisions. The tool is integrated with content from PubMed, a global database of peer-reviewed medical research, aligning regional clinical research with international standards. Dx is in ongoing localization for markets across Asia and was recently implemented as a learning resource for public health staff in Sumedang Regency and Sumedang General Hospital.
Docquity and exMedio will kick-off the collaboration by running a Proof of Concept (PoC) from June to September 2025, engaging over 74,000 Japanese doctors. The initiative will explore the application of Dx – now localized for the Japanese market from language to comprehensive clinical guidelines – in real-world clinical settings, examining search behavior, knowledge retrieval patterns, and user feedback to further optimize its utility in HCPs’ daily workflows.
“exMedio’s deep understanding of the Japanese medical community and its trusted Hippocra platform make them an ideal partner to extend our mission of developing AI solutions that address evolving healthcare needs in Japan,” said Indranil Roychowdhury, CEO and Co-Founder of Docquity. “By combining exMedio’s established network of healthcare professionals with Docquity’s AI technology, this partnership holds immense promise for advancing physician-centric innovation and patient care in Japan and beyond.”
Dr. Sosuke Meshitsuka, Chief Medical Officer (CMO) of exMedio, commented: “Following its successful implementation in Indonesia, I am very excited to see how Dx can enhance the quality and speed of clinical decision-making in the Japanese healthcare setting. I joined exMedio to support the growth of ‘Hippocra’ with my clinical experience in haematology and home medicine, and my knowledge of corporate management. This PoC is an important opportunity for doctors to integrate AI into their practice and improve the quality of healthcare. We are determined to make this an initiative that brings sustainable value to healthcare in Japan, with an emphasis on the frontline perspective.”
Pending the PoC results, Docquity and exMedio will evaluate deeper integrations of generative AI into Japanese HCPs’ daily routines. This joint effort aims to create effective and culturally relevant AI-powered clinical support tools to redefine the Japanese healthcare landscape.
END
About Docquity, https://docquity.com/
Docquity is Southeast Asia’s largest community of verified healthcare professionals (HCPs). Our platform and services leverage data science to strengthen healthcare knowledge and interactions.
The Docquity vision is to connect HCPs to build healthier lives around the world at scale. Our platform helps HCPs learn, connect, and grow, while our deep network insights enable healthcare enterprises to understand, engage, and educate HCPs.
We are trusted by more than 410,000 HCPs across Southeast Asia, with offices in India, Indonesia, Malaysia, the Philippines, Singapore, Taiwan, Thailand, and Vietnam.
Docquity is available for download on Apple and Android devices.
For further information, please contact:
Reisha Nagrani
Director of Communications, Docquity
reisha@docquity.com
Therese Panganiban
Virtusio PR
+63 917 8210312
therese@virtusio.com
